Altamira Therapeutics Analysis
Altamira Therapeutics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Altamira Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Altamira Therapeutics is worth, separate from its market price. There are two main types of Altamira Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Altamira Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Altamira Therapeutics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Altamira Stock trading window is adjusted to America/New York timezone.
Altamira |
Altamira Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.08. Some equities with similar Price to Book (P/B) outperform the market in the long run. Altamira Therapeutics last dividend was issued on the 1st of May 2019. The entity had 1:20 split on the 13th of December 2023. Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Altamira Therapeutics Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda. Altamira Therapeutics is traded on NASDAQ Exchange in the United States. For more info on Altamira Therapeutics please contact the company at 441 295 5950 or go to https://altamiratherapeutics.com.Altamira Therapeutics Investment Alerts
| Altamira Therapeutics is not yet fully synchronised with the market data | |
| Altamira Therapeutics has some characteristics of a very speculative penny stock | |
| Altamira Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Altamira Therapeutics currently holds 99.66 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Altamira Therapeutics has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Altamira Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (3.87 M) with loss before overhead, payroll, taxes, and interest of (2.18 M). | |
| Altamira Therapeutics currently holds about 984.19 K in cash with (11.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29. |
Altamira Therapeutics Upcoming and Recent Events
Earnings reports are used by Altamira Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 21st of May 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Altamira Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.13 M.Altamira Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Altamira Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Altamira Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Altamira Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mollica Joseph A over two months ago Acquisition by Mollica Joseph A of 138 shares of Altamira Therapeutics subject to Rule 16b-3 | ||
Lokay Kevin G over three months ago Acquisition by Lokay Kevin G of 10000 shares of Altamira Therapeutics at 11.5 subject to Rule 16b-3 | ||
Carter Stephen over three months ago Disposition of 10000 shares by Carter Stephen of Altamira Therapeutics at 0.62 subject to Rule 16b-3 | ||
Mollica Joseph A over six months ago Acquisition by Mollica Joseph A of 198 shares of Altamira Therapeutics subject to Rule 16b-3 | ||
Schnittker Christopher P over six months ago Acquisition by Schnittker Christopher P of 18000 shares of Altamira Therapeutics at 5.15 subject to Rule 16b-3 | ||
Schnittker Christopher P over six months ago Acquisition by Schnittker Christopher P of 10000 shares of Altamira Therapeutics at 11.5 subject to Rule 16b-3 |
Altamira Therapeutics Outstanding Bonds
Altamira Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Altamira Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Altamira bonds can be classified according to their maturity, which is the date when Altamira Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Altamira Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Altamira Stock
If you are still planning to invest in Altamira Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Altamira Therapeutics' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |